Exhibition and Sponsorship at BigData in HealthCare TLV, April 16, 2019
IATI is Israel’s Umbrella Organization of the High-Tech, Life Sciences and other Advanced Technology Industries, with hundreds of paying members from every level and aspect of the ecosystem, including Venture Capital Funds, Israeli R&D Centers of Multinational Companies, Start-Ups, Incubators & Accelerators, leading global Stock Exchanges, Tech Transfer Organizations, Academic Institutions, Innovation Centers, Hospitals, Municipalities, service Providers and more. Through this broad range of members, IATI connects Israel’s tech ecosystem, provides solutions and support at all levels, and integrates the various sectors of the industry with strategic and ongoing governmental goals.
CDI-Negev, the Center for Digital Innovation, is a non-profit innovation center, founded by Israeli digital health entrepreneurs and Ben-Gurion University of the Negev and is located in Israel’s leading R&D center in Beer-Sheba. CDI brings together start-up companies, experienced entrepreneurs, researchers and investors with a personalized support system and a dedicated network of industry thought leaders committed to help the start-ups overcome barriers and achieve global success.
MDClone introduces the world’s first Healthcare Data Sandbox, unlocking healthcare data to enable limitless exploration, discovery and collaboration. The Sandbox is a big data platform that eliminates the barriers between data and those who can use it to transform care. Powered by its breakthrough Synthetic Data Engine, the Sandbox overcomes patient privacy restrictions, and together with its robust analytic capabilities data and insights are now at anyone’s fingertips. MDClone
The ARC (Accelerate Redesign Collaborate) Innovation Center, led by Dr Eyal Zimlichman, Sheba’s Chief Innovation Officer and Dr Nathalie Bloch, the Center’s Director, aims to bring new technologies into the hospital and community ecosystem in order to further improve patient care. It allows seamless integration between innovators, scientists, startups, high-level developers, large corporate companies, investors, and academia – all under one roof. The ARC Innovation Center is focused on digital health technologies, including precision medicine, big data and predictive analytics, telemedicine and mobile health. ARC
The Belong App is a patient engagement and navigation app with disruptive research platform for decision support.
The Belong platform centralizes everything patients need into one place, including direct chats with world-renown professionals. Belong works as a supportive and interactive patient community, which includes personalized content and updates, and advanced clinical trials search capability through an automated matching algorithm.
Through the use of proprietary Natural Language Processing engine, Medical OCR and Medical Neural Network technologies, Belong is transforming patient engagement data into actionable Clinical and Business intelligence insight. Supporting a wide range of healthcare applications including health economics, outcome research, personalized care, social impact and more. Our main services for healthcare institutions include:
- Clinical and business intelligence- insights based on accumulated patients real world data
- Patient support program – to meet patients’ outcomes and adherence
- Clinical trial recruiting
- Educational and awareness campaigns
DSG is a multidisciplinary group that specializes in the use of scientific tools and methodologies to extract and utilize knowledge and insights from information (data) in various formats employed by organizations and companies. We focus on varied methods of data analysis, such as supervised/unsupervised machine learning, and structured/unstructured data formats implementing data mining, text mining and graph mining algorithms. We provide a unique combination of specialties, with experts and researchers from different fields, each with extensive academic background, hands-on practical orientation, and many years of industry experience.
Takeda is a patient-focused, values-based, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future to people worldwide.
Our R&D efforts are focused on four therapeutic areas: Oncology, Gastroenterology (GI), Neuroscience and Rare Diseases. We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines.
Our passion and pursuit of potentially life-changing treatments for patients are deeply rooted in over 230 years of distinguished history in Japan.
Takeda has presence in approximately 80 countries, with leading positions in Japan and the U.S., respectively the third and first largest pharmaceutical markets in the world.
We will deliver highly innovative medicines and transformative care for more people globally.
We are committed to bringing Better Health and a Brighter Future to patients by translating science into highly-innovative medicines.
For further information:
Who is Janssen? We’re more than 30,000 people working hard to prevent, treat, cure and stop some of the most devastating and complex diseases of our time. From heart disease to HIV, Alzheimer’s disease to cancer, we are committed to issues that touch everyone’s lives.
Our mission is to transform individual lives and fundamentally change the way diseases are managed, interpreted, and prevented. We believe that challenging something is the best way to change it. So every day, in more than 150 countries, we bring cutting-edge science and the most creative minds in the industry together to think differently about diseases. We aim not only to innovate but also to empower people with the tools they need to make informed decisions and achieve the best possible results for their health.
We are looking at a future where the world of healthcare will be challenged by informed and empowered patients. We work for change that will improve access to medicines: the best available treatment at an affordable price. That’s why we at Janssen strive to provide access to effective and affordable medicines and related healthcare services to the people who need them.
Our Focus Areas
We are developing treatments for patients in six important therapeutic areas of healthcare:
· Cardiovascular & Metabolism
· Infectious Diseases & Vaccines
· Pulmonary Hypertension
Roche Israel is part of a global Roche group, pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible (“Doing now what Patients need next”).
Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics.
Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry nine years in a row by the Dow Jones Sustainability Indices (DJSI).
The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2016 employed more than 94,000 people worldwide. In 2016, Roche invested CHF 9.9 billion in R&D and posted sales of CHF 50.6 billion. Genentech, in the United States, is a wholly owned member of the Roche Group.
Roche is the majority shareholder in Chugai Pharmaceutical, Japan.
Alongside the International Conference we will hold an exhibition featuring key players in the field of Big Data in HealthCare.
Exhibitors, organizations, electronic and printed media, Trade Associations and all others connected with the subjects of the Exhibition and Conference, are invited to sponsor the event.
Please contact us for more information.
1. Company logo on all electronic communication, including show’s website, electronic official catalog and pre-registration forms. Limited to 5 companies.
2. Roll-up on the event site (supplied by the sponsor) displayed in different locations around the event. Limited to 3 companies.
3. Promotional material in the visitor’s bag. Limited to 4 companies.
4. Short presentation of your company on the Exhibition’s website. The website will be “Live” from now until the next annual show. Logo on the directional signs on site. Limited to 4 companies.
5. Promotional material on the Conference lunch tables.
6. Small logo flags (supplied by sponsor) on Event registration desk.
7. Conference refreshment break.
8. Writing pads and pens. Limited to 1 company.
Platinum Sponsorship includes all 8 categories
Gold Sponsorship includes 6 categories
Silver Sponsorship includes 4 categories
Other sponsorship opportunities will become available. Please contact us for details
Israeli exhibitors must add VAT at the current rate to the prices quoted
ITEX, Event Organizer
Established in 1975, ITEX International Exhibition Services Ltd organizes exhibitions and conferences linking Israeli companies with global markets READ MORE